Significant association of multiple human cytomegalovirus genomic loci with glioblastoma multiforme samples

Journal of Virology

Volumn 86, Issue 2, 2012, Pages 854-864

  Ranganathan, Padhma ^a,b   Clark, Paul A ^c   Kuo, John S ^a,c   Salamat, M Shahriar ^a   Kalejta, Robert F ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CANCER GROWTH; CONTROLLED STUDY; CYTOMEGALOVIRUS; DISEASE ACTIVITY; DISEASE COURSE; EPILEPSY; FROZEN SECTION; GENE LOCUS; GENETIC ASSOCIATION; GENOMICS; GLIOBLASTOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRUS CELL INTERACTION; VIRUS GENOME;

BRAIN NEOPLASMS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; GENOME, VIRAL; GLIOBLASTOMA; HUMANS; RETROSPECTIVE STUDIES;

HERPESVIRIDAE; HUMAN HERPESVIRUS 5;

EID: 84856836761     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06097-11     Document Type: Article

References (43)

1. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57:289-300.
2. Britt W. 2008. Manifestations of human cytomegalovirus infection: pro-posed mechanisms of acute and chronic disease. Curr. Top. Microbiol. Immunol. 325:417-470.
3. Brune W. 2011. Inhibition of programmed cell death by cytomegaloviruses. Virus Res. 157:144-150.
4. Caposio P, Orloff SL, Streblow DN. 2011. The role of cytomegalovirus in angiogenesis. Virus Res. 157:204-211.
5. Cobbs CS, et al. 2002. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res. 62:3347-3350.
6. Dziurzynski K, et al. 2011. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype. Clin. Cancer Res. 17:4642-4649.
7. Fields BN, Knipe DM, Howley PM, Griffin DE. 2007. Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
8. Fortunato EA, Dell'Aquila ML, Spector DH. 2000. Specific chromosome 1 breaks induced by human cytomegalovirus. Proc. Natl. Acad. Sci. U. S. A. 97:853-858.
9. Glantz M, Kesari S, Recht L, Fleischhack G, Van Horn A. 2009. Understanding the origins of gliomas and developing novel therapies: cerebrospinal fluid and subventricular zone interplay. Semin. Oncol. 36: S17-S24.
10. Hanahan D, Weinberg RA. 2011. Hallmarks of cancer: the next generation. Cell 144:646-674.
11. Hume AJ, Kalejta RF. 2009. Regulation of the retinoblastoma proteins by the human herpesviruses. Cell Div. 4:1.
12. Hwang J, Saffert RT, Kalejta RF. 2011. Elongin B-mediated epigenetic alteration of viral chromatin correlates with efficient human cytomegalovirus gene expression and replication. mBio 2(2):e00023-11.
13. Hwang J, Winkler L, Kalejta RF. 2011. Ubiquitin-independent proteasomal degradation during oncogenic viral infections. Biochim. Biophys. Acta 1816:147-157.
14. King JY, et al. 2005. Pathway analysis of coronary atherosclerosis. Physiol. Genomics 23:103-118.
15. Lau SK, et al. 2005. Lack of association of cytomegalovirus with human brain tumors. Mod. Pathol. 18:838-843.
16. Lucas KG, Bao L, Bruggeman R, Dunham K, Specht C. 2011. The detection of CMV pp65 and IE1 in glioblastoma multiforme. J. Neurooncol. 103:231-238.
17. Michaelis M, Doerr HW, Cinatl J. 2009. The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia 11:1-9.
18. Michaelis M, Doerr HW, Cinatl J Jr. 2009. Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med. Microbiol. Immunol. 198:79-81.
19. Millhouse S, et al. 2010. Evidence that herpes simplex virus DNA derived from quiescently infected cells in vitro, and latently infected cells in vivo, is physically damaged. J. Neurovirol. 16:384-398.
20. Mitchell DA, et al. 2008. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro-Oncology 10:10-18.
21. Moore PS, Chang Y. 2010. Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat. Rev. Cancer 10:878-889.
22. Ohgaki H. 2009. Epidemiology of brain tumors. Methods Mol. Biol. 472: 323-342.
23. Parsons DW, et al. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321:1807-1812.
24. Poltermann S, et al. 2006. Lack of association of herpesviruses with brain tumors. J. Neurovirol. 12:90-99.
25. Powers C, DeFilippis V, Malouli D, Fruh K. 2008. Cytomegalovirus immune evasion. Curr. Top. Microbiol. Immunol. 325:333-359.
26. Renzette N, Bhattacharjee B, Jensen JD, Gibson L, Kowalik TF. 2011. Extensive genome-wide variability of human cytomegalovirus in congenitally infected infants. PLoS Pathog. 7:e1001344.
27. Rodriguez-Inigo E, et al. 2005. Percentage of hepatitis C virus-infected hepatocytes is a better predictor of response than serum viremia levels. J. Mol. Diagn. 7:535-543.
28. Sabatier J, et al. 2005. Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br. J. Cancer 92: 747-750.
29. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R. 2008. Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol. 116:79-86.
30. Shen Y, Zhu H, Shenk T. 1997. Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate "hit-and-run" oncogenic transformation in cooperation with the adenovirus E1A proteins. Proc. Natl. Acad. Sci. U. S. A. 94:3341-3345.
31. Slinger E, et al. 2010. HCMV-encoded chemokine receptor US28 mediates proliferative signaling through the IL-6-STAT3 axis. Sci. Signal. 3:ra58.
32. Soderberg-Naucler C. 2008. HCMV microinfections in inflammatory diseases and cancer. J. Clin. Virol. 41:218-223.
33. Sokal RR, Rohlf FJ. 1995. Biometry: the principles and practice of statistics in biological research, 3rd ed. Freeman, New York, NY.
34. Soroceanu L, Cobbs CS. 2011. Is HCMV a tumor promoter? Virus Res. 157:193-203.
35. Straat K, et al. 2009. Activation of telomerase by human cytomegalovirus. J. Natl. Cancer Inst. 101:488-497.
36. Streblow DN, Dumortier J, Moses AV, Orloff SL, Nelson JA. 2008. Mechanisms of cytomegalovirus-accelerated vascular disease: induction of paracrine factors that promote angiogenesis and wound healing. Curr. Top. Microbiol. Immunol. 325:397-415.
37. Tsutsui Y, Kawasaki H, Kosugi I. 2002. Reactivation of latent cytomegalovirus infection in mouse brain cells detected after transfer to brain slice cultures. J. Virol. 76:7247-7254.
38. Vereide DT, Sugden B. 2011. Lymphomas differ in their dependence on Epstein-Barr virus. Blood 117:1977-1985.
39. Vomaske J, et al. 2010. HCMV pUS28 initiates pro-migratory signaling via activation of Pyk2 kinase. Herpesviridae 1:2.
40. Waller EC, Day E, Sissons JG, Wills MR. 2008. Dynamics of T cell memory in human cytomegalovirus infection. Med. Microbiol. Immunol. 197:83-96.
41. Yu Y, Clippinger AJ, Alwine JC. 2011. Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol. 19:360-367.
42. Yuan X, et al. 2004. Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392-9400.
43. Zhu Y, Parada LF. 2002. The molecular and genetic basis of neurological tumours. Nat. Rev. Cancer. 2:616-626.